Over a 10-year period, METS-IR effectively predicted CV events among patients with PsA, with values greater than 2.48 at baseline conferring the greatest risk.

Authors defined metabolic syndrome as “the set of factors that increase the risk of cardiovascular disease and diabetes, such ...